Notably, levels of CLEC11A are elevated in the CSF of patients with chronic inflammatory demyelinating polyneuropathy and in the blood of patients with chronic spinal cord injuries over time, suggesting its potential involvement in chronic neurodegenerative processes [56,57]. Here, CLEC11A is linked to chronic inflammatory demyelinating polyradiculoneuropathy.